Engineered Microorganisms With Enhanced Protein Expression
Summary
The USPTO published patent application US20260109937A1 filed by Nathan Crook, Deniz Durmusoglu, Ibrahim Al'Abri, and Daniel Haller on September 22, 2023, covering genetically modified microorganisms engineered for enhanced production and secretion of peptides and polypeptides. The application specifically discloses yeast cells engineered with improved protein expression capabilities, with CPC classifications including C12N 1/18, C12N 9/90, and related biotechnology codes.
“The present disclosure provides materials and methods related to the production of peptides and polypeptides from engineered microorganisms.”
About this source
GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 236 changes logged to date.
What changed
The USPTO published a new patent application disclosing engineered microorganisms, specifically yeast cells, with genetically enhanced protein expression and secretion capabilities. The application names four inventors and was originally filed on September 22, 2023 under Application No. 19114168.
For biotechnology and pharmaceutical companies engaged in recombinant protein production, this patent application indicates competitive activity in the field of engineered yeast expression systems. Companies developing similar microbial expression platforms should review their own IP positions and freedom-to-operate status. The application does not impose compliance obligations but signals ongoing innovation in this technical space.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ENGINEERED MICROORGANISMS WITH ENHANCED PROTEIN EXPRESSION AND SECRETION
Application US20260109937A1 Kind: A1 Apr 23, 2026
Inventors
Nathan Crook, Deniz Durmusoglu, Ibrahim Al'Abri, Daniel Haller
Abstract
The present disclosure provides materials and methods related to the production of peptides and polypeptides from engineered microorganisms. In particular, the present disclosure provides compositions and methods for producing a genetically modified microorganism (e.g., yeast cell) with enhanced protein expression and/or secretion.
CPC Classifications
C12N 1/18 C12N 9/90 C07K 2319/036 C12R 2001/85 C12Y 504/02007
Filing Date
2023-09-22
Application No.
19114168
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.